| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CCELCryo-Cell International, Inc. | 27.15M | 3.37 | 67.40 | 2.05% | 1.26% | 13.29% | ||
| HCSGHealthcare Services Group, Inc. | 1.67B | 21.77 | 26.88 | 7.08% | 2.2% | 8.01% | 8.32% | 0.03 |
| SOLVSolventum Corporation | 12.87B | 74.20 | 8.36 | 0.86% | 18.69% | 30.82% | 1.00 | |
| AMSAmerican Shared Hospital Services | 13.74M | 2.11 | 6.39 | 32.9% | -7.65% | -7.87% | 0.77 | |
| SYRASyra Health Corp. Class A Common Stock | 60K | 0.10 | -0.19 | 44.73% | -16.89% | -57.31% | 0.16 | |
| AMNAMN Healthcare Services, Inc. | 987.48M | 19.48 | -5.06 | -21.26% | -3.5% | -14.9% | 24.26% | 1.55 |
| CCRNCross Country Healthcare, Inc. | 280.81M | 8.70 | -19.77 | -33.46% | -1.39% | -3.84% | 39.67% | 0.01 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Nov 2015 | Nov 2016 | Nov 2017 | Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 21.09M | 23.13M | 25.38M | 29.22M | 31.82M | 31.15M | 28.88M | 30.34M | 31.34M | 31.99M |
| Revenue Growth % | 4.79% | 9.66% | 9.76% | 15.1% | 8.89% | -2.1% | -7.26% | 5.03% | 3.32% | 2.05% |
| Cost of Goods Sold | 5.63M | 5.77M | 6.72M | 8.54M | 10.04M | 9.66M | 8.99M | 8.79M | 8.44M | 7.95M |
| COGS % of Revenue | 26.7% | 24.97% | 26.49% | 29.23% | 31.54% | 31.01% | 31.12% | 28.98% | 26.93% | 24.85% |
| Gross Profit | 15.46M | 17.35M | 18.66M | 20.68M | 21.78M | 21.49M | 19.9M | 21.54M | 22.9M | 24.04M |
| Gross Margin % | 73.3% | 75.03% | 73.51% | 70.77% | 68.46% | 68.99% | 68.88% | 71.02% | 73.07% | 75.15% |
| Gross Profit Growth % | 6.67% | 12.24% | 7.53% | 10.82% | 5.33% | -1.33% | -7.42% | 8.29% | 6.3% | 4.96% |
| Operating Expenses | 12.53M | 14.93M | 13.65M | 15.9M | 15.13M | 13.83M | 15.88M | 17.52M | 35.26M | 20.56M |
| OpEx % of Revenue | 59.4% | 64.56% | 53.79% | 54.43% | 47.55% | 44.4% | 54.97% | 57.75% | 112.49% | 64.27% |
| Selling, General & Admin | 12.39M | 14.72M | 13.48M | 15.63M | 14.89M | 14.29M | 14.63M | 15.58M | 17.12M | 18.52M |
| SG&A % of Revenue | 58.74% | 63.66% | 53.11% | 53.5% | 46.8% | 45.89% | 50.63% | 51.36% | 54.61% | 57.9% |
| Research & Development | 45.78K | 53.1K | 41.16K | 91.84K | 30.14K | 23.85K | 49.87K | 384.79K | 1.17M | 1.24M |
| R&D % of Revenue | 0.22% | 0.23% | 0.16% | 0.31% | 0.09% | 0.08% | 0.17% | 1.27% | 3.74% | 3.88% |
| Other Operating Expenses | 92.11K | 154.67K | 131.61K | 180.26K | 206.24K | -489.53K | 1.22M | 1.55M | 16.92M | 794.32K |
| Operating Income | 2.93M | 433.59K | 5.01M | 5.19M | 5.06M | 7.66M | 4.02M | 4.02M | -12.3M | 3.48M |
| Operating Margin % | 13.91% | 1.87% | 19.72% | 17.76% | 15.91% | 24.6% | 13.91% | 13.27% | -39.26% | 10.88% |
| Operating Income Growth % | 48.05% | -85.22% | 1054.59% | 3.66% | -2.44% | 51.33% | -47.55% | 0.16% | -405.73% | 128.29% |
| EBITDA | 3.17M | 720.24K | 5.24M | 5.51M | 5.46M | 8.3M | 5.34M | 5.83M | -10.59M | 3.96M |
| EBITDA Margin % | 15.05% | 3.11% | 20.63% | 18.85% | 17.17% | 26.64% | 18.5% | 19.23% | -33.8% | 12.39% |
| EBITDA Growth % | 34.61% | -77.31% | 627.01% | 5.16% | -0.77% | 51.86% | -35.59% | 9.15% | -281.59% | 137.42% |
| D&A (Non-Cash Add-back) | 241.21K | 286.65K | 230K | 317.33K | 401.31K | 635.98K | 1.33M | 1.81M | 1.71M | 483.52K |
| EBIT | 2.25M | -1.53M | 4.93M | 5.16M | 5.09M | 6.58M | 3.99M | 4.84M | -12.13M | 939.44K |
| Net Interest Income | -1.3M | -947.34K | -1.3M | -1.55M | -1.7M | -1.54M | -1.38M | -1.52M | -1.24M | -1.86M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.3M | 947.34K | 1.3M | 1.55M | 1.7M | 1.54M | 1.38M | 1.52M | 1.24M | 1.86M |
| Other Income/Expense | -1.98M | -2.91M | -1.38M | -1.57M | -1.67M | -2.62M | -1.41M | -705.52K | -1.06M | -676.16K |
| Pretax Income | 949.52K | -2.48M | 3.62M | 3.62M | 3.39M | 5.04M | 2.61M | 3.32M | -13.36M | 2.8M |
| Pretax Margin % | 4.5% | -10.72% | 14.28% | 12.38% | 10.66% | 16.18% | 9.04% | 10.94% | -42.64% | 8.77% |
| Income Tax | -7.16M | -1.16M | 1.31M | 4.47M | 1.1M | 1.41M | 527.71K | 547.54K | -3.84M | 2.4M |
| Effective Tax Rate % | 853.73% | 53.25% | 63.89% | -23.63% | 67.55% | 71.93% | 79.79% | 83.5% | 71.25% | 14.34% |
| Net Income | 8.11M | -1.32M | 2.32M | -854.82K | 2.29M | 3.62M | 2.08M | 2.77M | -9.52M | 402.1K |
| Net Margin % | 38.43% | -5.71% | 9.12% | -2.93% | 7.2% | 11.64% | 7.21% | 9.14% | -30.38% | 1.26% |
| Net Income Growth % | 1364.24% | -116.29% | 275.28% | -136.92% | 367.98% | 58.23% | -42.52% | 33.02% | -443.57% | 104.22% |
| Net Income (Continuing) | 8.11M | -1.32M | 2.32M | -854.82K | 2.29M | 3.62M | 2.08M | 2.77M | -9.52M | 402.1K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.83 | -0.16 | 0.30 | -0.11 | 0.27 | 0.45 | 0.25 | 0.33 | -1.14 | 0.05 |
| EPS Growth % | 1560% | -119.28% | 287.5% | -136.67% | 345.45% | 66.67% | -44.44% | 32% | -445.45% | 104.39% |
| EPS (Basic) | 0.85 | -0.16 | 0.33 | -0.11 | 0.29 | 0.48 | 0.26 | 0.33 | -1.14 | 0.05 |
| Diluted Shares Outstanding | 9.8M | 8.11M | 7.65M | 7.46M | 8.41M | 8.14M | 8.36M | 8.48M | 8.34M | 8.21M |
| Basic Shares Outstanding | 9.54M | 8.11M | 7.06M | 7.46M | 8.41M | 8.14M | 8.14M | 8.47M | 8.34M | 8.13M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | 276.85% | - | 502.5% |
| Nov 2015 | Nov 2016 | Nov 2017 | Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 10.35M | 9.01M | 12.74M | 29.54M | 15.39M | 18.56M | 15.78M | 9.61M | 9.45M | 12.55M |
| Cash & Short-Term Investments | 4.76M | 4.12M | 6.72M | 6.92M | 7.45M | 10.45M | 8.34M | 1.72M | 980.25K | 3.5M |
| Cash Only | 4.15M | 3.5M | 6.28M | 6.04M | 6.54M | 10.36M | 8.26M | 1.7M | 406.07K | 560.96K |
| Short-Term Investments | 610.42K | 624.22K | 439.32K | 875.69K | 904.05K | 88.48K | 75.41K | 17.62K | 574.18K | 2.94M |
| Accounts Receivable | 3.06M | 4.05M | 5.13M | 5.87M | 6.1M | 6.32M | 5.25M | 6.04M | 6.58M | 7.31M |
| Days Sales Outstanding | 52.93 | 63.96 | 73.7 | 73.3 | 69.95 | 74.09 | 66.38 | 72.72 | 76.58 | 83.41 |
| Inventory | 475.61K | 361.14K | 314.57K | 16.04M | 1.08M | 927.32K | 921.21K | 851.23K | 768.88K | 657.7K |
| Days Inventory Outstanding | 30.83 | 22.83 | 17.07 | 685.4 | 39.44 | 35.05 | 37.4 | 35.34 | 33.24 | 30.2 |
| Other Current Assets | 1.63M | 78.45K | 206.14K | 254.47K | 260.4K | 244.7K | 711.21K | 426.88K | 512.06K | 454.6K |
| Total Non-Current Assets | 9.14M | 10.53M | 11.17M | 12.85M | 27.5M | 27.64M | 44.88M | 55.28M | 51.77M | 52.12M |
| Property, Plant & Equipment | 879.07K | 979.46K | 882.38K | 1.49M | 1.85M | 1.94M | 4.15M | 14.21M | 22.03M | 22.7M |
| Fixed Asset Turnover | 23.99x | 23.61x | 28.77x | 19.57x | 17.23x | 16.06x | 6.97x | 2.14x | 1.42x | 1.41x |
| Goodwill | 1.78M | 0 | 0 | 1.94M | 1.94M | 1.94M | 1.94M | 1.94M | 1.94M | 1.94M |
| Intangible Assets | 516.33K | 261K | 226.42K | 1.34M | 1.25M | 1.53M | 16.21M | 15.15M | 989.12K | 921.25K |
| Long-Term Investments | 0 | 0 | 0 | 308K | 308K | 308K | 308K | 308K | 0 | 0 |
| Other Non-Current Assets | 40.61K | 25.5K | 28.89K | 113.89K | 13.07M | 11.56M | 10.26M | 9.92M | 6.31M | 5.76M |
| Total Assets | 19.5M | 19.54M | 23.91M | 42.39M | 42.89M | 46.2M | 60.66M | 64.89M | 61.22M | 64.68M |
| Asset Turnover | 1.08x | 1.18x | 1.06x | 0.69x | 0.74x | 0.67x | 0.48x | 0.47x | 0.51x | 0.49x |
| Asset Growth % | 90.98% | 0.21% | 22.37% | 77.29% | 1.17% | 7.73% | 31.3% | 6.97% | -5.65% | 5.65% |
| Total Current Liabilities | 10.42M | 13.11M | 13.94M | 15.43M | 15.43M | 16.41M | 21.07M | 19.48M | 20.86M | 21.6M |
| Accounts Payable | 1.33M | 1.49M | 1.93M | 1.26M | 1.37M | 957.39K | 1.49M | 1.61M | 3.17M | 1.88M |
| Days Payables Outstanding | 86.12 | 93.89 | 104.68 | 53.93 | 49.79 | 36.18 | 60.49 | 66.64 | 137.25 | 86.44 |
| Short-Term Debt | 307.42K | 0 | 0 | 0 | 3.1M | 3.1M | 1.9M | 2.42M | 1.39M | 3.69M |
| Deferred Revenue (Current) | 6.78M | 7.07M | 7.43M | 8.37M | 8.88M | 9.18M | 9.36M | 9.59M | 9.7M | 9.79M |
| Other Current Liabilities | 0 | 2M | 2M | 3.1M | 0 | 0 | 4.96M | 1.98M | 1.2M | 1.42M |
| Current Ratio | 0.99x | 0.69x | 0.91x | 1.91x | 1.00x | 1.13x | 0.75x | 0.49x | 0.45x | 0.58x |
| Quick Ratio | 0.95x | 0.66x | 0.89x | 0.87x | 0.93x | 1.07x | 0.71x | 0.45x | 0.42x | 0.55x |
| Cash Conversion Cycle | -2.37 | -7.1 | -13.91 | 704.77 | 59.6 | 72.96 | 43.3 | 41.41 | -27.43 | 27.17 |
| Total Non-Current Liabilities | 14.04M | 21.84M | 22.47M | 35.87M | 34.41M | 32.45M | 35.4M | 46.93M | 51.39M | 56.29M |
| Long-Term Debt | 868.95K | 0 | 0 | 0 | 0 | 2.84M | 0 | 8.58M | 8.43M | 8.31M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 23.63K | 610.99K | 313.3K | 851.94K | 505.05K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.3M | 9.24M | 6.72M | 15.55M | 10.78M | 2.38M | 3.52M | 2.04M | 919.23K | 922.02K |
| Total Liabilities | 24.46M | 34.95M | 36.41M | 51.3M | 49.84M | 48.87M | 56.48M | 66.41M | 72.25M | 77.89M |
| Total Debt | 1.18M | 9.82M | 7.3M | 12.94M | 8.96M | 6.24M | 2.82M | 11.61M | 10.9M | 12.93M |
| Net Debt | -2.98M | 6.32M | 1.02M | 6.9M | 2.42M | -4.12M | -5.44M | 9.91M | 10.49M | 12.37M |
| Debt / Equity | - | - | - | - | - | - | 0.67x | - | - | - |
| Debt / EBITDA | 0.37x | 13.63x | 1.39x | 2.35x | 1.64x | 0.75x | 0.53x | 1.99x | - | 3.26x |
| Net Debt / EBITDA | -0.94x | 8.77x | 0.19x | 1.25x | 0.44x | -0.50x | -1.02x | 1.70x | - | 3.12x |
| Interest Coverage | 2.25x | 0.46x | 3.84x | 3.35x | 2.97x | 4.96x | 2.91x | 2.64x | -9.95x | 1.87x |
| Total Equity | -4.96M | -15.41M | -12.5M | -8.91M | -6.95M | -2.67M | 4.18M | -1.52M | -11.03M | -13.22M |
| Equity Growth % | 53.72% | -210.51% | 18.89% | 28.75% | 21.95% | 61.67% | 257% | -136.43% | -623.69% | -19.81% |
| Book Value per Share | -0.51 | -1.90 | -1.63 | -1.19 | -0.83 | -0.33 | 0.50 | -0.18 | -1.32 | -1.61 |
| Total Shareholders' Equity | -4.96M | -15.41M | -12.5M | -8.91M | -6.95M | -2.67M | 4.18M | -1.52M | -11.03M | -13.22M |
| Common Stock | 122.6K | 125.04K | 129K | 135.96K | 135.99K | 136.34K | 146.66K | 148.48K | 148.49K | 148.7K |
| Retained Earnings | -25.47M | -26.79M | -24.47M | -25.33M | -22.44M | -18.82M | -16.74M | -21.64M | -31.16M | -32.78M |
| Treasury Stock | -8.32M | -19.12M | -19.57M | -19.57M | -20.56M | -20.56M | -20.81M | -22.63M | -23.43M | -24.86M |
| Accumulated OCI | 169.93K | 34.41K | 40.87K | 340.98K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nov 2015 | Nov 2016 | Nov 2017 | Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 4.85M | 4.99M | 5.72M | 5.33M | 6.32M | 8.47M | 7.93M | 8.57M | 8.92M | 6.01M |
| Operating CF Margin % | 23% | 21.57% | 22.53% | 18.25% | 19.87% | 27.18% | 27.44% | 28.26% | 28.46% | 18.79% |
| Operating CF Growth % | 212.03% | 2.81% | 14.64% | -6.73% | 18.56% | 33.9% | -6.38% | 8.16% | 4.05% | -32.61% |
| Net Income | 8.11M | -1.32M | 2.32M | -854.82K | 2.29M | 3.62M | 2.08M | 2.77M | -9.52M | 402.1K |
| Depreciation & Amortization | 241.21K | 286.65K | 230K | 317.33K | 401.31K | 635.98K | 1.33M | 1.81M | 1.71M | 1.02M |
| Stock-Based Compensation | 602.98K | 1.77M | 971.73K | 478.38K | 397.77K | 622.12K | 301.62K | 461.35K | 816.64K | 781.13K |
| Deferred Taxes | -7.37M | -1.91M | -774.81K | 2.38M | -1.52M | -1.28M | -1.65M | -1.73M | -6.75M | -309.27K |
| Other Non-Cash Items | 1.4M | 4.62M | 202.45K | 583.8K | 2.47M | 1.11M | 1M | 1.01M | 16.68M | 417K |
| Working Capital Changes | 1.87M | 1.54M | 2.77M | 2.43M | 2.28M | 3.76M | 4.86M | 4.25M | 5.99M | 3.7M |
| Change in Receivables | 313.94K | -1.62M | -1.15M | -1.35M | -997.12K | -828.59K | 532.79K | -1.72M | 6.58M | -2M |
| Change in Inventory | 117.23K | 114.47K | 46.58K | 316.65K | -27.42K | 454.94K | 210.28K | 490K | 0 | 429.18K |
| Change in Payables | 335.71K | 329.56K | 443.11K | -666.89K | 107.46K | -411.72K | 532.38K | 115.53K | 0 | -423.72K |
| Cash from Investing | -719.35K | -369.73K | 93.03K | -11.28M | -690.66K | 357.49K | -6.95M | -15.28M | -8.14M | -4.88M |
| Capital Expenditures | -108.48K | -342.98K | -98.33K | -646.16K | -662.29K | -449.96K | -6.95M | -17.17M | -6.84M | -2.4M |
| CapEx % of Revenue | 0.51% | 1.48% | 0.39% | 2.21% | 2.08% | 1.44% | 24.07% | 56.59% | 21.82% | 7.51% |
| Acquisitions | -375.37K | 0 | 0 | -10.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -235.5K | -26.75K | 191.36K | -136.25K | 0 | 0 | 0 | 1.87M | -800K | -1.1M |
| Cash from Financing | -3.26M | -5.27M | -3.03M | 5.71M | -5.13M | -5M | -3.07M | 147.86K | -2.07M | -979.12K |
| Debt Issued (Net) | -123.63K | 9.27M | -2.65M | 5.71M | -4.1M | -3.1M | -4.1M | 9.29M | -1.21M | 2.16M |
| Equity Issued (Net) | -1000K | -1000K | -446.62K | 0 | -992.24K | 0 | -249.38K | -1000K | -799.04K | -1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.67M | 0 | -2.02M |
| Share Repurchases | -3.21M | -10.81M | -446.62K | 0 | -992.24K | 0 | -249.38K | -1.82M | -799.04K | -1.42M |
| Other Financing | 69.85K | -3.74M | 64.7K | 1.63K | -39.3K | -1.9M | 1.28M | 354.77K | -67.5K | 304.4K |
| Net Change in Cash | 872.89K | -652.28K | 2.78M | -239.12K | 501K | 3.82M | -2.1M | -6.56M | -1.3M | 154.89K |
| Free Cash Flow | 4.74M | 4.64M | 5.62M | 4.69M | 5.66M | 8.02M | 974.92K | -8.6M | 1.28M | 3.61M |
| FCF Margin % | 22.49% | 20.08% | 22.14% | 16.04% | 17.79% | 25.74% | 3.38% | -28.33% | 4.09% | 11.28% |
| FCF Growth % | 230.68% | -2.07% | 20.99% | -16.6% | 20.77% | 41.61% | -87.84% | -981.69% | 114.9% | 181.64% |
| FCF per Share | 0.48 | 0.57 | 0.73 | 0.63 | 0.67 | 0.98 | 0.12 | -1.01 | 0.15 | 0.44 |
| FCF Conversion (FCF/Net Income) | 0.60x | -3.78x | 2.47x | -6.24x | 2.76x | 2.34x | 3.80x | 3.09x | -0.94x | 14.95x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 1.04M | 1.26M | 1.81M | 1.98M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 3.53M | 1.57M | 1.82M | 2.72M |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | - | - | 274.3% | 208.38% | - | - |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | - | 84.69% | -235.27% | - |
| Gross Margin | 73.3% | 75.03% | 73.51% | 70.77% | 68.46% | 68.99% | 68.88% | 71.02% | 73.07% | 75.15% |
| Net Margin | 38.43% | -5.71% | 9.12% | -2.93% | 7.2% | 11.64% | 7.21% | 9.14% | -30.38% | 1.26% |
| Debt / Equity | - | - | - | - | - | - | 0.67x | - | - | - |
| Interest Coverage | 2.25x | 0.46x | 3.84x | 3.35x | 2.97x | 4.96x | 2.91x | 2.64x | -9.95x | 1.87x |
| FCF Conversion | 0.60x | -3.78x | 2.47x | -6.24x | 2.76x | 2.34x | 3.80x | 3.09x | -0.94x | 14.95x |
| Revenue Growth | 4.79% | 9.66% | 9.76% | 15.1% | 8.89% | -2.1% | -7.26% | 5.03% | 3.32% | 2.05% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics